Logotype for Aether Industries Limited

Aether Industries (AETHER) Q3 25/26 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Aether Industries Limited

Q3 25/26 earnings summary

9 Jul, 2026

Executive summary

  • Q3 FY26 revenue grew 44% year-over-year to INR 3,171 million, with EBITDA up 75% and PAT up 49%, driven by increased CEM contracts and LSM demand.

  • Strong performance across all business verticals, with export revenue at 36% and domestic at 64%.

  • Major capacity expansions at Site 3++ and Site 5 completed, with commercial production to commence by March 2026.

  • 15 new customers onboarded and 36 customer/certification audits completed in 9M FY26.

  • Board approved unaudited standalone and consolidated financial results for Q3 and nine months ended December 31, 2025, reviewed by independent auditors.

Financial highlights

  • Q3 FY26 operating revenue: INR 3,171 million; EBITDA: INR 1,083 million; PAT: INR 645 million; EBITDA margin at 34%, up from 28% in Q3 FY25.

  • Nine-month FY26 revenue at INR 8,534 million, up 43% year-over-year; EBITDA up 75% to INR 2,716 million; PAT at INR 1,655 million, up 53%.

  • EPS (consolidated, Q3): INR 4.86; EPS (standalone, Q3): INR 3.92.

  • One-time FLOP insurance claim of INR 15 crore included in other income.

  • Paid-up equity share capital: INR 1,326.13 million.

Outlook and guidance

  • Targeting 70% of future revenue from CRAMS and CEM, 30% from large-scale manufacturing.

  • Sustainable EBITDA margin expected around 29-30% due to normalization after one-time items.

  • Site 3++ and Site 5 to reach 45-50% and 35-40% utilization respectively in FY27.

  • R&D expansion ongoing, with new fume hoods and a new R&D center under development.

  • Management is evaluating the impact of new labour codes and expects no material effect on results.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more